{
  "id": 10346253,
  "title": "Tempus AI CEO Ryan Fukushima sells $49,000 in stock",
  "url": "https://urgent.news/2026/09/28/tempus-ai-ceo-ryan-fukushima-sells-49-000-in-stock",
  "topic": "ai",
  "section": "AI",
  "published": "2026-09-28T02:30:49.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/tempus-ai-ceo-ryan-fukushima-sells-49000-in-stock-93CH-4919283"
  },
  "original_language": "en",
  "account": "Tempus AI CEO Ryan Fukushima sold 700 shares of the company's Class A Common Stock for $49,000 on September 16, 2026, according to a SEC filing. The stock price has since risen to $85.01, marking a 99% gain over the past six months. This surge has pushed the stock above InvestingPro's Fair Value estimate, categorizing it as an overvalued equity. The sale was executed under a Rule 10b5-1 trading plan initiated by Fukushima's spouse on March 12, 2026. Currently, Fukushima holds 562,463 shares directly and 15,874 shares indirectly. Tempus AI has received mixed analyst assessments, with Piper Sandler upgrading the stock to Overweight with a $76 target, Cantor Fitzgerald initiating coverage with an Overweight rating at $80, while Goldman Sachs and Rothschild Redburn have initiated coverage with Neutral ratings at $75 and $67, respectively. H.C. Wainwright raised its price target to $66, maintaining a Buy rating due to positive Phase 3 INTerpath-001 results from Merck and Moderna, which are anticipated to benefit Tempus AI's acquisition of Personalis.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Tempus AI CAO Ryan Bartolucci sells $529,650 in stock",
        "url": "https://urgent.news/2026/09/28/tempus-ai-cao-ryan-bartolucci-sells-529-650-in-stock",
        "published": "2026-09-28T02:30:54.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}